Physician profile
Stephanie E Boring
NPI 1942398987
$6,564.51
in general payments reported to CMS, 2019-2025
42 companies · $1,962 in 2025
The $1,962 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $896 · 2022: $927 · 2023: $1,084 · 2024: $1,696 · 2025: $1,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,742.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,804.63 | 2021-2025 | |
| Novo Nordisk INC | $612.74 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $475.18 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $472.66 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $338.87 | 2022-2025 | Krystexxa, Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $282.25 | 2021-2025 | Caplyta |
| Astellas Pharma US INC | $232.80 | 2021-2024 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $232.24 | 2021-2025 | Rexulti |
| Exact Sciences Corporation | $213.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $149.42 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $148.52 | 2021-2024 | Xarelto, Spravato |
| Novartis Pharmaceuticals Corporation | $129.37 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.78 | 2021-2025 | Jardiance |
| Pfizer INC. | $116.13 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $114.93 | 2025 | Fanapt |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Boring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.